• 1
    Wills-Karp, M., Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 1999. 17: 255281.
  • 2
    Bousquet, J., Chanez, P., Lacoste, J. Y. et al., Eosinophilic inflammation in asthma. N. Engl. J. Med. 1990. 323: 10331039.
  • 3
    Shirakawa, I., Deichmann, K. A., Izuhara, I., Mao, I., Adra, C. N. and Hopkin, J. M., Atopy and asthma: genetic variants of IL-4 and IL-13 signaling. Immunol. Today 2000. 21: 6064.
  • 4
    Chung, K. F. and Barnes, P. J., Cytokines in asthma. Thorax 1999. 54: 825857.
  • 5
    Tillie-Leblond, I., Pugin, J., Marquette, C. H., Lamblin, C., Saulnier, F., Brichet, A., Wallaert, B., Tonnel, A. B. and Gosset, P., Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am. J. Respir. Crit. Care Med. 1999. 159: 487494.
  • 6
    Sousa, A. R., Lane, S. J., Nakhosteen, J. A., Lee, T. H. and Poston, R. N., Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am. J. Respir. Crit. Care Med. 1996. 154: 10611066.
  • 7
    Borish, L., Mascali, J. J., Dishuck, J., Beam, W. R., Martin,R. J. and Rosenwasser, L. J., Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J. Immunol. 1992. 149: 30783082.
  • 8
    Lilly, C. M., Nakamura, H., Kesselman, H., Nagler-Anderson, C., Asano, K., Garcia-Zepeda, E. A., Rothenberg, M. E., Drazen, J. M. and Luster, A. D., Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 1997.99: 17671773.
  • 9
    Broide, D. H., Campbell, K., Gifford, T. and Sriramarao, P., Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium. Blood 2000. 95: 263269.
  • 10
    Hakonarson, H., Herrick, D. J., Serrano, P. G. and Grunstein, M. M., Autocrine role of interleukin 1beta in altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 1997. 99: 117124.
  • 11
    Sims, J. E. and Dower, S. K., Interleukin-1 receptors. Eur. Cytokine Netw. 1994. 5: 539546.
  • 12
    Colotta, F., Dower, S. K., Sims, J. E. and Mantovani, A., The type II ‘decoy’ receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 1994. 15: 562566.
  • 13
    Arend, W. P., Malyak, M., Guthridge, C. J. and Gabay, C., Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 1998. 16: 2755.
  • 14
    Dinarello, C. A., Biologic basis for interleukin-1 in disease. Blood 1996. 87: 20952147.
  • 15
    Dinarello, C. A., Interleukin-1. Cytokine Growth Factor Rev. 1997. 8: 253265.
  • 16
    Lichtman, A. H., Chin, J., Schmidt, J. A. and Abbas, A. K., Role ofinterleukin 1 in the activation of T lymphocytes. Proc. Natl. Acad. Sci. USA 1988. 85: 96999703.
  • 17
    Huber, M., Beuscher, H. U., Rohwer, P., Kurrle, R., Rollinghoff, M. and Lohoff, M., Costimulation via TCR and IL-1 receptor reveals a novel IL-1alpha-mediated autocrine pathway of Th2 cell proliferation. J. Immunol. 1998. 160: 42424247.
  • 18
    Weaver, C. T., Hawrylowicz, C. M. and Unanue, E. R., T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. USA 1988. 85: 81818185.
  • 19
    Staruch, M. J. and Wood, D. D., The adjuvanticity of interleukin 1 in vivo. J. Immunol. 1983. 130: 21912194.
  • 20
    Reed, S. G., Pihl, D. L., Conlon, P. J. and Grabstein, K. H., IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. J. Immunol. 1989. 142: 31293133.
  • 21
    Nakae, S., Asano, M., Horai, R., Sakaguchi, N. and Iwakura, Y., IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J. Immunol. 2001. 167: 9097.
  • 22
    Glaccum, M. B., Stocking, K. L., Charrier, K., Smith, J. L., Willis, C. R., Maliszewski, C., Livingston, D. J., Peschon, J. J. and Morrissey, P. J., Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 1997. 159: 33643371.
  • 23
    Satoskar, A. R., Okano, M., Connaughton, S., Raisanen-Sokolwski, A., David, J. R. and Labow, M., Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol. 1998. 28: 20662074.
  • 24
    Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata,T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., Eguchi, N., Urade, Y., Yoshida, N., Kimura, K., Mizoguchi, A., Honda, Y., Nagai, H. and Narumiya, S., Prostaglandin D2 as a mediator of allergic asthma. Science 2000. 287: 20132017.
  • 25
    Kobayashi, T., Miura, T., Haba, T., Sato, M., Serizawa, I., Nagai, H. and Ishizaka, K., An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol. 2000. 164: 38553861.
  • 26
    Deurloo, D. T., van Esch, B. C., Hofstra, C. L., Nijkamp, F. P. and van Oosterhout, A. J., CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model. Am. J. Respir. Cell Mol. Biol. 2001. 25: 751760.
  • 27
    Wang, J., Homer, R. J., Chen, Q. and Elias, J. A., Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J. Immunol. 2000. 165: 40514061.
  • 28
    Eriksson, U., Kurrer, M. O., Sonderegger, I., Iezzi, G., Tafuri, A., Hunziker, L., Suzuki, S., Bachmaier, K., Bingisser, R. M., Penninger, J. M. and Kopf, M., Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J. Exp. Med. 2003. 197: 323331.
  • 29
    Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A. and Bottomly, K., Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 2002. 196: 16451651.
  • 30
    Kopf, M., Coyle, A. J., Schmitz, N., Barner, M., Oxenius, A., Gallimore, A., Gutierrez-Ramos, J. C. and Bachmann, M. F., Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J. Exp. Med. 2000. 192: 5361.